Effect of HERG-like potassium channel blocker on the carotid body chemoreception.
Osanai
Shinobu
S
First Department of Medicine, Asahikawa Medical College 2-1-1-1 Midorigaoka Higashi, Asahikawa 078-8510, Japan.
Takahashi
Toru
T
Nakano
Hitoshi
H
Ohsaki
Yoshinobu
Y
Kikuchi
Kenjiro
K
D000818:Animals; D002344:Carotid Body / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology; D027682:Cation Transport Proteins / Q000187:drug effects / Q000378:metabolism; D002628:Chemoreceptor Cells / Q000187:drug effects* / Q000378:metabolism*; D004594:Electrophysiology; D051638:Ether-A-Go-Go Potassium Channels; D000860:Hypoxia / Q000378:metabolism / Q000503:physiopathology; D066298:In Vitro Techniques; D010627:Phenethylamines / Q000494:pharmacology; D026902:Potassium Channel Blockers / Q000494:pharmacology*; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D024642:Potassium Channels, Voltage-Gated; D011817:Rabbits; D013449:Sulfonamides / Q000494:pharmacology
D027682:Cation Transport Proteins; D051638:Ether-A-Go-Go Potassium Channels; C092509:KCNH6 protein, human; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D013449:Sulfonamides; C063533:dofetilide